BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21696674)

  • 1. [New and future cancer diagnostics].
    Højgaard L
    Ugeskr Laeger; 2011 Jun; 173(24):1715-8. PubMed ID: 21696674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
    Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the best way to diagnose and stage malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):254-9. PubMed ID: 21044972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of imaging techniques for cancer patients in The Netherlands : A Delphi study.
    Postma TJ; Alers JC; Terpstra S; Zuurbier A
    Eur J Health Econ; 2006 Jun; 7(2):117-22. PubMed ID: 16691374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the diagnostic methods on the therapeutic strategies.
    Greco M; Agresti R; Giovanazzi R
    Q J Nucl Med; 1998 Mar; 42(1):66-80. PubMed ID: 9646647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future aspects of molecular imaging.
    Mottaghy FM
    Methods; 2009 Jun; 48(2):81-2. PubMed ID: 19520300
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor models and specific contrast agents for small animal imaging in oncology.
    Ni Y; Wang H; Chen F; Li J; DeKeyzer F; Feng Y; Yu J; Bosmans H; Marchal G
    Methods; 2009 Jun; 48(2):125-38. PubMed ID: 19328231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in biomarkers for cancer diagnosis and treatment.
    Manne U; Srivastava RG; Srivastava S
    Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern imaging methods versus clinical assessment in the evaluation of hospital in-patients with suspected pancreatic disease.
    Rösch T; Schusdziarra V; Born P; Bautz W; Baumgartner M; Ulm K; Lorenz R; Allescher HD; Gerhardt P; Siewert JR; Classen M
    Am J Gastroenterol; 2000 Sep; 95(9):2261-70. PubMed ID: 11007227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
    Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
    J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern development of imaging procedures in oncology.
    Rotte KH
    Arch Geschwulstforsch; 1990; 60(4):317-22. PubMed ID: 2202272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
    Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
    Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Localization diagnostics of neuroendocrine gastrointestinal tumours].
    Kjaer A; Knigge U; Mortensen J; Hansen CP; Fallentin E
    Ugeskr Laeger; 2010 Oct; 172(43):2953-6. PubMed ID: 21040674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The fundamental problems and evaluation criteria for rational imaging diagnosis in oncology].
    Rotte KH
    Arch Geschwulstforsch; 1990; 60(1):36-40. PubMed ID: 2106866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular imaging; current status and future prospects in USA].
    Kobayashi H
    Nihon Rinsho; 2007 Feb; 65(2):204-10. PubMed ID: 17302262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid imaging technology: from dreams and vision to clinical devices.
    Patton JA; Townsend DW; Hutton BF
    Semin Nucl Med; 2009 Jul; 39(4):247-63. PubMed ID: 19497402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of radiation and choice of imaging.
    Herfarth H; Palmer L
    Dig Dis; 2009; 27(3):278-84. PubMed ID: 19786752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.